Search Within

Mikhail Roshal

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (11)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (32)
  2. Population Sciences Research Program (32)
  3. Center for Hematologic Malignancies (31)
  4. Department of Medicine (31)
  5. Hematologic Malignancies, Division of (31)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Andriy Derkach (21)
  2. Ahmet Dogan (18)
  3. Wenbin Xiao (16)
  4. Maria Arcila (14)
  5. Qi Gao (13)
  6. Sergio Giralt (12)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (2)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Blood (11)
  2. Blood Advances (4)
  3. American Journal of Hematology (2)
  4. Cytometry Part B—Clinical Cytometry (2)
  5. Haematologica (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Wiley Blackwell (3)
  3. Ferrata Storti Foundation (2)
  4. John Wiley & Sons, Inc. (2)
  5. Nature Publishing Group (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
    Journal Article

    Lewis, N. E.; Gao, Q.; Petrova-Drus, K.; Pulitzer, M.; Sigler, A.; Baik, J.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2022)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Chan, A.; Derkach, A.; Liu, Y.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M. E.; Mata, D. A.; Dogan, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
    Journal Article

    Xiao, W.; Chan, A.; Waarts, M. R.; Mishra, T.; Liu, Y.; Cai, S. F.; Yao, J.; Gao, Q.; Bowman, R. L.; Koche, R. P.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save